Good Job Laurie! I know this will help many. Thanks, Lillian
-----Original Message-----
From: dlpooleparty@mindspring.com <dlpooleparty@mindspring.com>
To: MOL Angels <mol-cancer@lists.meds.com>
Date: Wednesday, March 31, 1999 5:20 PM
Subject: [MOL] New Drugs
>Anybody know about any of these drugs? Apparently FDA approved in 1998...
>
>Actiq; Treatment for Cancer Pain; Anesta Corporation; Approved November
>1998
>Anzemet; Treatment for the prevention of nausea and vomiting associated
>with chemotherapy and surgery; Hoechst Marion Roussel; Approved February
>1998
>Gemzar; Treatment for Lung Cancer; Eli Lilly; Approved August 1998
>Neupogen; Treatment for slow white blood cell recovery following
>chemotherapy; Amgen; Approval April 1998
>Photofrin; Treatment for early-stage, microinvasive endobronchial
non-small
>cell lung cancer; QLT
>Therapeutics; Approved January 1998
>Proleukin; Treatment for metastatic melanoma; Chiron Corporation; Approved
>January 1998
>Sclerosol Intrapleural Aerosol; Treatment for malignant pleural effusions;
>Bryan Corporation; Approved January 1998
>Zofran; Treatment for postoperative vomiting and nausea in adults; Glaxo
>Wellcome; Approved April 1998
>
>Laurie
>
>------------------------------------------------------------------------
>This is an automatically-generated notice. If you'd like to be removed
>from the mailing list, please visit the Medicine-On-Line Discussion Forum
>at <http://www.meds.com/con_faq.html>, or send an email message to:
>majordomo@lists.meds.com
>with the subject line blank and the body of the message containing the
line:
>unsubscribe mol-cancer your-email-address
>where the phrase your-email-address is replaced with your actual email
>address.
>------------------------------------------------------------------------
>
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
